Related references
Note: Only part of the references are listed.Mechanisms of Urokinase Plasminogen Activator (uPA)-mediated Atherosclerosis ROLE OF THE uPA RECEPTOR AND S100A8/A9 PROTEINS
Stephen D. Farris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Paraoxonase 1 (PON1) deficiency in mice is associated with reduced expression of macrophage SR-BI and consequently the loss of HDL cytoprotection against apoptosis
Bianca Fuhrman et al.
ATHEROSCLEROSIS (2010)
Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: A role for PPAR-gamma pathway
Jasmin Khateeb et al.
ATHEROSCLEROSIS (2010)
The urokinase receptor: Focused cell surface proteolysis, cell adhesion and signaling
Francesco Blasi et al.
FEBS LETTERS (2010)
Low human paraoxonase predicts cardiovascular events in Japanese patients with type 2 diabetes
Yukio Ikeda et al.
ACTA DIABETOLOGICA (2009)
Urokinase activates macrophage PON2 gene transcription via the PI3K/ROS/MEK/SREBP-2 signalling cascade mediated by the PDGFR-β
Bianca Fuhrman et al.
CARDIOVASCULAR RESEARCH (2009)
The roles of PON1 and PON2 in cardiovascular disease and innate immunity
Diana M. Shih et al.
CURRENT OPINION IN LIPIDOLOGY (2009)
Reactive oxygen species regulate the generation of urokinase plasminogen activator in human hepatoma cells via MAPK pathways after treatment with hepatocyte growth factor
Kyung Hee Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2009)
Human carotid atherosclerotic plaque increases oxidative state of macrophages and low-density lipoproteins, whereas paraoxonase 1 (PON1) decreases such atherogenic effects
Hagai Tavori et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
The urokinase receptor as an entertainer of signal transduction
Silvia D'Alessio et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Urokinase plasminogen activator upregulates paraoxonase 2 expression in macrophages via an NADPH oxidase-dependent mechanism
Bianca Fuhrman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Paraoxonase-1 deficiency in mice predisposes to vascular inflammation, oxidative stress, and thrombogenicity in the absence of hyperlipidemia
Dominic S. Ng et al.
CARDIOVASCULAR PATHOLOGY (2008)
A rapid micro chromatin immunoprecipitation assay (mu ChIP)
John Arne Dahl et al.
NATURE PROTOCOLS (2008)
Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophages through activation of SREBP-1 in a PI3-kinase and MEK-dependent manner
Bianca Fuhrman et al.
ATHEROSCLEROSIS (2007)
Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor γ
Elke Burgermeister et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Urokinase induces ROS production in vascular smooth muscle cells
O. S. Plekhanova et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2006)
Urokinase plasminogen activator stimulates vascular smooth muscle cell proliferation via redox-dependent pathways
M Menshikov et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions
S Yoon et al.
GROWTH FACTORS (2006)
Iron-ascorbic acid-induced oxidant stress and its quenching by paraoxonase 1 in HDL and the liver: Comparison between humans and rats
K Trudel et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
New insights on oxidative stress in the artery wall
R Stocker et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice
O Rozenberg et al.
ATHEROSCLEROSIS (2005)
Urokinase-induced signaling in human vascular smooth muscle cells is mediated by PDGFR-β
J Kiyan et al.
EMBO JOURNAL (2005)
Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine
M Rosenblat et al.
ATHEROSCLEROSIS (2005)
Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-ST-segment elevation myocardial infarction
M Gyongyosi et al.
AMERICAN HEART JOURNAL (2004)
Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death
AE Cozen et al.
CIRCULATION (2004)
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: Studies in PON1-knockout mice
O Rozenberg et al.
FREE RADICAL BIOLOGY AND MEDICINE (2003)
Increased expression of urokinase during atherosclerotic lesion development causes arterial constriction and lumen loss, and accelerates lesion growth
M Falkenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism
S Deakin et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Evaluation of monensin and brefeldin A for flow cytometric determination of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha in monocytes
AJ Schuerwegh et al.
CYTOMETRY (2001)
Urokinase stimulates human vascular smooth muscle cell migration via a phosphatidylinositol 3-kinase-Tyk2 interaction
A Kusch et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Nonproteolytic role for the urokinase receptor in cellular migration in vivo
DA Waltz et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2000)
Share Paper
